SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-19-006066
Filing Date
2019-03-04
Accepted
2019-03-04 18:39:36
Documents
1
Period of Report
2019-03-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4522
  Complete submission text file 0001567619-19-006066.txt   5876
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 PROFESSIONAL DRIVE SUITE 400 GAITHERSBURG MD 20879
Business Address
Abdun-Nabi Daniel (Reporting) CIK: 0001380187 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33137 | Film No.: 19655869